Breast cancer screening should begin at age 40

New SBI and ACR recommendations suggest breast cancer screening should begin at age 40 – Breast cancer screening should begin at age 40 and earlier in high-risk patients, suggested by the Society of Breast Imaging (SBI) and the American College of Radiology (ACR).

MRI detects breast cancer at earlier stage

Magnetic resonance imaging (MRI) detects breast cancer at earlier stage – Magnetic resonance imaging (MRI) coupled with mammography detects almost all cancers at an early stage, thereby reducing the incidence of advanced stage breast cancer in high-risk women.

Caution about mammography use among women younger than 40 years

Mammography use among women younger than 40 years old differ between minority populations – Breast cancer screening guidelines generally recommend mammography begin at age 40. However, based on prior national research, an estimated 34 percent of non-Hispanic black women, 30 percent of non-Hispanic white women and 22 percent of Hispanic women aged 30 to 39 have reported having a mammogram.

Mammogram policy unchanged for breast cancer screening, US

Secretary Sebelius Statement on New Breast Cancer Recommendations – Mammogram policy unchanged for breast cancer screening in US. – HHS Secretary Kathleen Sebelius issued the following statement today on new breast cancer screening recommendations from the U.S. Preventive Services Task Force:

Less hormone therapy use in women reduced breast cancer rate

Scientists uncover new key to the puzzle of hormone therapy and breast cancer – The decreased use of postmenopausal hormone therapy has played a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer, revealed by researchers.

African American women get delay in breast cancer related care

Study finds delay in follow-up among African-American women receiving abnormal breast finding – African-American women face obstacles to receive appropriate breast cancer?related care in US. There is a significant delay in follow-up times among African-American women after the finding of a suspicious breast abnormality.

DASH diet reduces women’s risk of heart failure

Diet prescribed to lower blood pressure also reduces women’s risk of heart failure. – The DASH diet was initially developed to help patients lower their blood pressure, but a large study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) demonstrates that women who followed the diet also significantly reduced their risk of developing heart failure.

Breast cancer linked to inherited high breast density

Mother-daughter breast density study points way to earlier cancer risk assessment – A unique mother-daughter study that used magnetic resonance to measure breast density in younger women shows that percent of breast water could be linked to the risk of breast cancer in middle age and older.

Breast cancer screening mammography not a true life saver

For a woman in the screening subset of mammography-detectable cancers, there is a less than 5% chance that a mammogram will save her life. – Women are often told that mammography saves lives. But rarely is the question asked, ‘how often?’

New breast imaging BSGI effective in detection of breast cancers

New breast imaging technology – breast specific gamma imaging – BSGI targets hard-to-detect cancers – Breast-specific gamma imaging (BSGI) is effective in the detection of cancers not found on mammograms or by clinical exam, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Some breast cancers may regress naturally

Some breast cancers detected by repeated mammographic screening would not persist to be detectable by a single mammogram at the end of 6 years, and this raises the possibility that the natural course of some screen-detected invasive breast cancers is to spontaneously regress. – Breast cancer rates increased significantly in four Norwegian counties after women there began undergoing mammography every two years, according to a report in the November 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Combined hormone therapy increases lobular breast cancer risk

Fred Hutchinson Cancer Research Center leads first study designed to evaluate the association between combined HRT use and the risk of lobular breast cancers. – Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | SpiritIndia